XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 60 filers reported holding XENON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,833,361 | +528.2% | 191,011 | +130.2% | 0.00% | +200.0% |
| Q3 2021 | $1,247,000 | -22.9% | 82,967 | -4.8% | 0.00% | 0.0% |
| Q2 2021 | $1,618,000 | +48.7% | 87,156 | +39.3% | 0.00% | 0.0% |
| Q1 2021 | $1,088,000 | -12.2% | 62,568 | -24.4% | 0.00% | 0.0% |
| Q4 2020 | $1,239,000 | +2000.0% | 82,787 | +1555.7% | 0.00% | – |
| Q3 2020 | $59,000 | -11.9% | 5,000 | 0.0% | 0.00% | – |
| Q2 2020 | $67,000 | +21.8% | 5,000 | 0.0% | 0.00% | – |
| Q1 2020 | $55,000 | -16.7% | 5,000 | 0.0% | 0.00% | – |
| Q4 2019 | $66,000 | +17.9% | 5,000 | -19.3% | 0.00% | – |
| Q3 2019 | $56,000 | -47.2% | 6,198 | -42.2% | 0.00% | – |
| Q2 2019 | $106,000 | -2.8% | 10,721 | 0.0% | 0.00% | – |
| Q1 2019 | $109,000 | +47.3% | 10,721 | -8.5% | 0.00% | – |
| Q4 2018 | $74,000 | -52.3% | 11,721 | 0.0% | 0.00% | – |
| Q3 2018 | $155,000 | +675.0% | 11,721 | +433.3% | 0.00% | – |
| Q2 2018 | $20,000 | +25.0% | 2,198 | -33.0% | 0.00% | – |
| Q1 2018 | $16,000 | +60.0% | 3,280 | 0.0% | 0.00% | – |
| Q3 2017 | $10,000 | -41.2% | 3,280 | -40.7% | 0.00% | – |
| Q2 2017 | $17,000 | -41.4% | 5,530 | -22.5% | 0.00% | – |
| Q1 2017 | $29,000 | -48.2% | 7,137 | 0.0% | 0.00% | – |
| Q4 2016 | $56,000 | -3.4% | 7,137 | 0.0% | 0.00% | – |
| Q3 2016 | $58,000 | +38.1% | 7,137 | 0.0% | 0.00% | – |
| Q2 2016 | $42,000 | -16.0% | 7,137 | 0.0% | 0.00% | – |
| Q1 2016 | $50,000 | -12.3% | 7,137 | 0.0% | 0.00% | – |
| Q4 2015 | $57,000 | -13.6% | 7,137 | -11.2% | 0.00% | – |
| Q3 2015 | $66,000 | -37.1% | 8,037 | -11.1% | 0.00% | – |
| Q2 2015 | $105,000 | – | 9,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |